Feature | Coronavirus (COVID-19) | October 02, 2020

Cardiac Arrest With Poor Survival Common in Sickest COVID-19 Patients

Very ill COVID-19 patients have a high rate of in-hospital sudden cardiac arrest and a very low survival rate.

Very ill COVID-19 patients have a high rate of in-hospital sudden cardiac arrest and very low survival rates. Getty Images

October 2, 2020 — Even when a sudden cardiac arrest happens inside a top hospital, where a code blue team is readily available, most people will not survive. This has become a particular problem with COVID-19 (SARS-CoV-2) patients.

This year, while researchers continued exploring how to improve dismal cardiac arrest survival rates,[1] clinicians started noticing a new population of patients who seemed to be experiencing cardiac arrest quite often — those hospitalized for COVID-19 infection.

This sparked an observational study led by experts at the Michigan Medicine Frankel Cardiovascular Center and Brigham and Women’s Hospital that leveraged data from 68 hospitals across the United States, just published in The BMJ.[2] The article is titled "In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study."

Researchers reviewed data from more than 5,000 U.S. patients, including those at Michigan Medicine, who were hospitalized in the intensive care unit for COVID-19. Fourteen percent of them experienced cardiac arrest within two weeks of being admitted to the ICU.

“Cardiac arrest is common in older patients with COVID-19, and survival rates after an arrest are poor,” says lead study author Salim Hayek, M.D., an assistant professor of internal medicine at Michigan Medicine and a cardiologist at the Frankel CVC. “This is the first multicenter study to investigate in-hospital cardiac arrest in people with COVID-19 infection.”

Along with older patients, those more likely to experience cardiac arrest included black patients as well as those admitted to hospitals with fewer ICU beds.

“One of the more interesting findings was that patients who were admitted to smaller hospitals were more likely to experience cardiac arrest,” said co-senior author David Leaf, M.D., MMSc, an assistant professor of medicine at Harvard Medical School. “Further, admission to a smaller hospital was independently associated with an increased risk of death among those who received CPR.”

The researchers encourage medical centers to consider how they will manage high rates of cardiac arrest in their sickest patients with COVID-19, especially if future patient surges occur.

“In general, only around one-fifth of people survive in-hospital cardiac arrest,” says co-senior author Brahmajee Nallamothu, M.D., M.P.H., a professor of internal medicine at Michigan Medicine and an interventional cardiologist at the Frankel CVC, who has extensively studied in-hospital arrest procedures and outcomes.

“The numbers for patients with COVID-19 look worse; however, younger patients who receive CPR have reasonable survival rates compared with other critically-ill patients, though less than 3% of people older than 80 who received CPR lived long enough to go home from the hospital.”

CPR for Patients With COVID-19

Some have questioned whether patients with COVID-19 should be given CPR. In addition to concerns about the effectiveness, there is also worry about the chances of health care providers becoming infected and being taken out of circulation because COVID-19 can spread during resuscitation. Hospitals have strict protocols in place that require providers be suited up in personal protective equipment before getting close to patients with a confirmed or suspected COVID-19 infection, but there is still a risk.

Despite these concerns, Hayek and colleagues found that all patients who did not have a do-not-resuscitate order received CPR. About a third of patients older than 80 received CPR, while more than three-quarters of those younger than age 45 did.

However, only 12% of those patients given CPR survived.

“These data should encourage people to have more discussions about end-of-life wishes, including decisions about resuscitation, ideally before anyone even becomes severely sick,” Hayek says.

That is because in COVID-19, unexpected complications can arise quickly.

Leaf adds that the acute severity of illness may have played a larger role in the cardiac arrest rates than existing heart disease, which was not independently associated with arrest rates, such as in the case of one previously healthy COVID-19 patient without a cardiac history who experienced cardiac arrest four times.[3]

Other common complications of COVID-19 include blood clots and acute kidney injury.

And going home from the hospital after surviving cardiac arrest and COVID-19 is not the end of the health struggles, it is simply an initial victory.

Researchers say, in the small sample size of patients with COVID-19 who were able to leave the hospital after receiving CPR, nearly half of them (20 out of 48 people) went home with a moderate to severe neurological impairment.

This is the latest project to come from the Study of the Treatment and Outcomes in Critically Ill Patients with COVID-19 (STOP-COVID) group led by Harvard’s Leaf, which includes detailed data on patients with COVID-19 infection who were admitted to ICUs at one of 68 hospitals across the country between March and June. 

“It’s impressive that this group led by David and Salim got together under stressful times to put together such a wonderful resource for asking these real world questions,” Nallamothu said. “It has provided those of us studying resuscitation in other contexts with invaluable information.”

Along with individual researchers’ support from the National Institutes of Health (NIH), the Frankel CVC funded this project in its pivot to address the pandemic with the COVID-19 Impact Researcher Ignitor Fund.

 

Related Cardiac COVID-19 Content:

ECMO Support Found Effective in Sickest of COVID-19 Patients

VIDEO: ECMO Support Effective in Sickest COVID-19 Patients — Interview with Ryan Barbaro, M.D.

ECMO Used to Treat Adult Respiratory Distress Syndrome Case

ECMO Support Found Effective in Sickest of COVID-19 Patients

Statins May Reduce COVID-19 Severity

Handheld Ultrasound Helps to Monitor COVID-19 Patients With Cardiac Conditions

AHA Explains Severe COVID-19 is Closely Associated With Heart Issues

The Cardiovascular Impact of COVID-19

Autopsies Reveal Surprising Cardiac Changes in COVID-19 Patients

How Cardiology Dealt With the COVID-19 Surge in New York City

Kawasaki-like Inflammatory Disease Affects Children With COVID-19 

New Research Highlights Blood Clot Dangers of COVID-19

 

References: 

1. Saket Girotra, Brahmajee K Nallamothu, John A Spertus, et al. Trends in survival after in-hospital cardiac arrest. N Engl J Med. 2012 Nov 15;367(20):1912-20. doi: 10.1056/NEJMoa1109148.

2. Salim S Hayek, Samantha K Brenner, Tariq U Azam, et al. In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study. BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m3513 Published 30 September 2020.

3. Haley Otman. Yoga Teacher Practicing Again After COVID-19 Triggered Cardiac Arrest. University of Michigan Health Blog. June 04, 2020. https://healthblog.uofmhealth.org/health-management/yoga-teacher-practicing-again-after-covid-19-triggered-cardiac-arrest.
 

Related Content

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

News | Cardiovascular Clinical Studies | July 22, 2020
July 22, 2020 — Eating chocolate at least once a week is linked with a reduced risk of heart disease, according to re
The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

News | Cardiovascular Clinical Studies | January 20, 2020
January 20, 2020 — Scientists at Los Alamos and international partners have created the first 3-D images of a special
Top Cardiology New in 2019 From the European Society of Cardioloigy (ESC)
News | Cardiovascular Clinical Studies | December 23, 2019
Environmental and lifestyle issues were popular this year, with pick up from both...
News | Cardiovascular Clinical Studies | November 26, 2019
November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have sele
FDA Issues Final Guidance on Live Case Presentations During IDE Clinical Trials
News | Cardiovascular Clinical Studies | July 10, 2019
The U.S. Food and Drug Administration (FDA) issued the final guidance “Live Case Presentations During Investigational...
Veradigm Partners With American College of Cardiology on Next-generation Research Registries
News | Cardiovascular Clinical Studies | July 03, 2019
The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to power the next...
New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp